THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21.

A. Bowcock; Lee Anderson; Lori S. Friedman; Donald M. Black; Sherri Osborne‐Lawrence; S E Rowell; Jeff Hall; E. Solomon; Mary‐Claire King

Abstract

In order to pinpoint the locale of the gene for early-onset familial breast and ovarian cancer (BRCA1), polymorphisms were developed within the locus for thyroid hormone receptor alpha (THRA1) and for several anonymous sequences at chromosome 17q12-q21. The THRA1 polymorphism is a dinucleotide repeat with 10 alleles and heterozygosity.79. Gene mapping in extended families with inherited, early-onset breast and ovarian cancer indicates that BRCA1 is distal to THRA1 and proximal to D17S183 (SCG43), an interval of < 4 cM. This locale excludes HER2, THRA1, WNT3, HOX2, NGFR, PHB, COLIA1, NME1, and NME2 as candidates for BRCA1 but does not exclude RARA or EDH17B. Resolving the remaining recombination events in these families by new polymorphisms in the THRA1-D17S183 interval will facilitate positional cloning of the breast-ovarian cancer gene on chromosome 17q12-q21.

Keywords

Loss of heterozygosityBiologyLocus (genetics)GeneticsOvarian cancerBreast cancerAlleleGeneCancer researchCancer

Affiliated Institutions

The University of Texas Southwestern Medical Center US

Related Publications

A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17

Ian R. Mackenzie , Matthew Baker , Gemma West +14 more

Over 30 different mutations have now been identified in MAPt that cause frontotemporal dementia (FTD). However, there are several families with FTD that show definite linkage to...

2006 Brain 104 citations

Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors

Manel Esteller

Silencing of the BRCA1 gene by promoter hypermethylation occurs in primary breast and ovarian carcinomas, especially in the presence of LOH and in specific histopathologic subgr...

2000 JNCI Journal of the National Cancer I... 1201 citations

Breast and Ovarian Cancer

Richard Wooster , Barbara Weber

espite years of intensive study and substantial progress in understanding susceptibility to breast and ovarian cancer, these diseases remain important causes of death in women.H...

2003 New England Journal of Medicine 602 citations

Genetic alterations in breast cancer

Ivan Bièche , Rosette Lidereau

Abstract The etiology of breast cancer involves a complex interplay of various factors, including genetic alterations. Many studies have been devoted to the identification and c...

1995 Genes Chromosomes and Cancer 302 citations

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

Lei Zheng , Lois A. Annab , Cynthia A. Afshari +2 more

Mutational inactivation of BRCA1 confers a cumulative lifetime risk of breast and ovarian cancers. However, the underlying basis for the tissue-restricted tumor-suppressive prop...

2001 Proceedings of the National Academy o... 211 citations

Publication Info

Year: 1993
Type: article
Volume: 52
Issue: 4
Pages: 718-22
Citations: 89
Access: Closed

External Links

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    A. Bowcock, 
                                
                                    Lee Anderson, 
                                
                                    Lori S. Friedman
                                
                                et al.
                            
                            (1993). 
                            THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21.. 
                            PubMed
                            , 52
                            (4)
                            , 718-22.